These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33474955)

  • 21. Efficacy and tolerability of once-daily OROS hydromorphone and twice-daily extended-release oxycodone in patients with chronic, moderate to severe osteoarthritis pain: results of a 6-week, randomized, open-label, noninferiority analysis.
    Hale M; Tudor IC; Khanna S; Thipphawong J
    Clin Ther; 2007 May; 29(5):874-888. PubMed ID: 17697906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analgesic efficacy of morphine sulfate immediate release vs. oxycodone/acetaminophen for acute pain in the emergency department.
    Fassassi C; Dove D; Davis A; Butt M; Masoudi A; Drapkin J; Gohel A; Silver M; Likourezos A; Motov S
    Am J Emerg Med; 2021 Aug; 46():579-584. PubMed ID: 33341323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized, double-blind, non-inferiority study of hydromorphone hydrochloride immediate-release tablets versus oxycodone hydrochloride immediate-release powder for cancer pain: efficacy and safety in Japanese cancer patients.
    Inoue S; Saito Y; Tsuneto S; Aruga E; Takahashi H; Uemori M
    Jpn J Clin Oncol; 2018 Jun; 48(6):542-547. PubMed ID: 29659913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Establishing the dosage equivalency of oxymorphone extended release and oxycodone controlled release in patients with cancer pain: a randomized controlled study.
    Gabrail NY; Dvergsten C; Ahdieh H
    Curr Med Res Opin; 2004 Jun; 20(6):911-8. PubMed ID: 15200750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized, double-blind, cross-over trial comparing safety and efficacy of oral controlled-release oxycodone with controlled-release morphine in patients with cancer pain.
    Bruera E; Belzile M; Pituskin E; Fainsinger R; Darke A; Harsanyi Z; Babul N; Ford I
    J Clin Oncol; 1998 Oct; 16(10):3222-9. PubMed ID: 9779695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
    Simpson DM; Messina J; Xie F; Hale M
    Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Feasibility study of rapid opioid rotation and titration.
    Korkmazsky M; Ghandehari J; Sanchez A; Lin HM; Pappagallo M
    Pain Physician; 2011; 14(1):71-82. PubMed ID: 21267044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fentanyl buccal tablet compared with immediate-release oxycodone for the management of breakthrough pain in opioid-tolerant patients with chronic cancer and noncancer pain: a randomized, double-blind, crossover study followed by a 12-week open-label phase to evaluate patient outcomes.
    Webster LR; Slevin KA; Narayana A; Earl CQ; Yang R
    Pain Med; 2013 Sep; 14(9):1332-45. PubMed ID: 23855816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized, placebo-controlled study of a new sublingual formulation of fentanyl citrate (fentanyl ethypharm) for breakthrough pain in opioid-treated patients with cancer.
    Novotna S; Valentova K; Fricova J; Richterova E; Harabisova S; Bullier F; Trinquet F;
    Clin Ther; 2014 Mar; 36(3):357-67. PubMed ID: 24508417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and tolerability of oxymorphone immediate release for acute postoperative pain after abdominal surgery: a randomized, double-blind, active- and placebo-controlled, parallel-group trial.
    Aqua K; Gimbel JS; Singla N; Ma T; Ahdieh H; Kerwin R
    Clin Ther; 2007 Jun; 29(6):1000-12. PubMed ID: 17692717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Controlled-release oxycodone tablets after transdermal-based opioid therapy in patients with cancer and non-cancer pain.
    Ravera E; Di Santo S; Bosco R; Arboscello C; Chiarlone R
    Aging Clin Exp Res; 2011; 23(5-6):328-32. PubMed ID: 22526067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of sustained-release morphine with sustained-release oxycodone in advanced cancer patients.
    Lauretti GR; Oliveira GM; Pereira NL
    Br J Cancer; 2003 Dec; 89(11):2027-30. PubMed ID: 14647133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination oxycodone 5 mg/ibuprofen 400 mg for the treatment of pain after abdominal or pelvic surgery in women: a randomized, double-blind, placebo- and active-controlled parallel-group study.
    Singla N; Pong A; Newman K;
    Clin Ther; 2005 Jan; 27(1):45-57. PubMed ID: 15763605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and Safety of High-Dose Controlled-Release Oxycodone in the Treatment of Moderate to Severe Pain in Patients with Advanced Cancer: A Retrospective Study.
    Wang W; Song Z; Zhang Y
    Med Sci Monit; 2018 Sep; 24():6750-6755. PubMed ID: 30229751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy, tolerability and acceptability of oxycodone for cancer-related pain in adults: an updated Cochrane systematic review.
    Schmidt-Hansen M; Bennett MI; Arnold S; Bromham N; Hilgart JS
    BMJ Support Palliat Care; 2018 Jun; 8(2):117-128. PubMed ID: 29331953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Controlled Release of Oxycodone as an Opioid Titration for Cancer Pain Relief: A Retrospective Study.
    Zhao S; Xu C; Lin R
    Med Sci Monit; 2020 Mar; 26():e920598. PubMed ID: 32225127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparing Patient-Controlled Analgesia Versus Non-PCA Hydromorphone Titration for Severe Cancer Pain: A Randomized Phase III Trial.
    Lin R; Lin S; Feng S; Wu Q; Fu J; Wang F; Li H; Li X; Zhang G; Yao Y; Xin M; Lai T; Lv X; Chen Y; Yang S; Lin Y; Hong L; Cai Z; Wang J; Lin G; Lin S; Zhao S; Zhu J; Huang C
    J Natl Compr Canc Netw; 2021 Aug; 19(10):1148-1155. PubMed ID: 34343968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effectiveness and safety of the rapid titration strategy of background controlled-release oxycodone hydrochloride for patients with moderate-to-severe cancer pain: A retrospective cohort study.
    Feng W; Wang Y; Ran F; Mao Y; Zhang H; Wang Q; Lin W; Wang Z; Hu J; Liao W; Zhang T; Chu Q; Xiong W; Yi T; Yi J; Ma S; Sun Y; Meng L; Liu C; Zhou S; Zheng D; Wang S; Lin H; Fang W; Li J; Wu M
    Front Med (Lausanne); 2022; 9():918468. PubMed ID: 36267618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selection of opioids for cancer-related pain using a biomarker: a randomized, multi-institutional, open-label trial (RELIEF study).
    Matsuoka H; Tsurutani J; Chiba Y; Fujita Y; Terashima M; Yoshida T; Sakai K; Otake Y; Koyama A; Nishio K; Nakagawa K
    BMC Cancer; 2017 Oct; 17(1):674. PubMed ID: 28985716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxycodone: a pharmacological and clinical review.
    Ordóñez Gallego A; González Barón M; Espinosa Arranz E
    Clin Transl Oncol; 2007 May; 9(5):298-307. PubMed ID: 17525040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.